| Literature DB >> 22824289 |
Johan Hartman1, Anders Ström, Jan-Åke Gustafsson.
Abstract
An increasing amount of evidence points at important roles for estrogen receptors in prostate carcinogenesis and progression. Of the two estrogen receptors, estrogen receptor β is the most prominent within the prostate gland. Although there is much yet to be known, the findings from the discovery of the receptor in 1996 until now point at a role of the receptor in maintaining differentiation and reducing cellular proliferation in the prostate. Moreover, estrogen receptor β is the main target for phytoestrogens, perhaps at least partially explaining the difference in incidence of prostate cancer in the Western world compared to Asia where the intake of soy-based, phytoestrogen-rich food is higher. The tumor suppressive capability of estrogen receptor β makes it a promising drug target for the treatment and prevention of prostate cancer. This review will focus on different aspects of estrogen receptor signaling and prostate cancer.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22824289 DOI: 10.1016/j.steroids.2012.07.002
Source DB: PubMed Journal: Steroids ISSN: 0039-128X Impact factor: 2.668